Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03761641 · ClinicalTrials.gov registry record

Pilot Study of NeuroTriage Device in Patients with Potential Brain Injury And/or Impairment

A clinical trial of Traumatic Brain Injury, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
24
Enrollment target
1
Study location

NCT03761641 is a study of Traumatic Brain Injury that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 24 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03761641, a study of Traumatic Brain Injury, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
24 participants
Enrollment target
1
Study location

Study Summary

This protocol is aimed at collecting oculomotor response data from a variety of brain injuries and impairments, and to secondarily evaluate the functionality and ease of use of the NeuroTriage device in the ED in patients with any presumed brain injury and/or impairment. For example, prior studies in adolescents with a concussion have shown that they tend to overshoot the pattern when asked to follow the movement of the lights in the binoculars

Conditions Studied

Interventions

  • OTHER Neurotriage

Study Locations (1)

Texas

  • Parkland Memorial Hospital - Dallas

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2015-03
Est. Completion 2015-11-15

What the Registry Record Tells You About NCT03761641

The ClinicalTrials.gov registry entry for NCT03761641 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (91% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Neurotriage is the first listed.

NCT03761641 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03761641 about?

NCT03761641 is a clinical study titled "Pilot Study of NeuroTriage Device in Patients with Potential Brain Injury And/or Impairment". This protocol is aimed at collecting oculomotor response data from a variety of brain injuries and impairments, and to secondarily evaluate the functionality and ease of use of the NeuroTriage device in the ED in patients with any presumed brain injury and/or impairment. For example, prior studies i...

What is the current status of trial NCT03761641?

This trial is currently completed. The enrollment target is 24 participants. The study started on 2015-03. Estimated completion is 2015-11-15.

What conditions does trial NCT03761641 study?

This clinical trial studies the following conditions: Traumatic Brain Injury.

What interventions are being tested in trial NCT03761641?

The interventions under investigation include: Neurotriage (OTHER).

Who is sponsoring clinical trial NCT03761641?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03761641 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.